Escalating Prescription Drug Costs: Ten New Breakthrough Drugs Are Just the Tip of the Iceberg

| April 2, 2015

article image
According to a new report by Avalere, over the next decade, ten breakthrough drugs are estimated to cost three government programs nearly $50 billion. Notably, the analysis adds that “total U.S. spending may exceed these estimates” when accounting for spending by other government agencies, costs to private sector payers, patient out-of-pocket costs, and the significant spending increases associated with off-label use. This price tag represents a ‘small subset’ of the total cost of the pharmaceutical pipeline for patients and the federal government.

Spotlight

iMEDGlobal Corporation

iMEDGlobal, an FMD K&L company, is an innovation-driven company providing platforms, services, and solutions to global life sciences clients to address critical business and scientific needs. Our platforms, services, and solutions include Pharmacovigilance, Regulatory Affairs, and Clinical Research. Led by a strong management team with decades of experience and thought leadership with leading pharmaceutical, biotech, medical devices, cosmetic and technology enterprises, iMEDGlobal is designed to deliver high-quality cost-effective solutions and services for our clients in the Americas, Europe, Asia and Australia. iMEDGlobal is a preferred partner to many top global life sciences companies who have placed their trust in our management team, infrastructure and capabilities.

OTHER ARTICLES

How AI and Big Data Will Disrupt Pharma’s Regulatory Compliance Standards

Article | March 4, 2020

The industry as we know it is changing. Pharmaceutical and life sciences companies across the globe are experiencing more pressure than ever to keep up with increased regulatory standards while moving at a pace that requires them to innovate in order to remain competitive. With more real-time automation and the steady increase in AI and Big Data sweeping the landscape, what used to be a slow-to-change and risk-averse industry is now expected to see a significant shift towards newer technology that focus on heightened regulatory standards. Here’s how your company can get ahead of what industry experts are calling, Pharma

Read More

How Can Medical Cannabis Help to Manage Pain Conditions? – The Cannabis Exchange

Article | February 11, 2020

Pain management is one of the most common reasons for the use of medical cannabis products. However, despite many jurisdictions – including Canada, Germany, and the Netherlands – now allowing the prescription of medical cannabis for this purpose, there remains little ‘high-quality’ evidence to support, or oppose its efficacy. Madden et al. (2018) set out to review the evidence available in order to determine the efficacy of medical cannabis when employed in the management of various forms of musculoskeletal pain. The researchers analysed various studies that assessed the use of cannabinoids in the treatment of arthritis pain; back pain; postoperative pain; and trauma-related pain. It is estimated that up to 30% of the population may suffer from a non-cancer-related pain condition. As such a high percentage of people suffer from these conditions, the development of simple and safe therapies is an essential area of research. This is particularly important as the therapeutic options for people with chronic pain are increasingly limited.

Read More

Enabling Active Pharma Ingredients for Batch Balancing and Integration to SAP EWM

Article | April 6, 2020

Batch and its Classification system are two most potent weapons used in Chemical, Pharma or Medical life science industry to record the potency of a batch or technically called as Active Pharma Ingredients(API). These material consist of one or more active ingredients, concentrates, carrier materials, or impurities, and so on. The potency of the active ingredients varies from batch to batch. The active ingredient is the substance of greatest interest in the bill of materials, the proportion of which may vary from batch to batch. Therefore, during creation of a process order, the system must be able to select and adjust the batches needed to obtain the required amount of active ingredient. Take an example of a drug hydroxychloroquine which is used as potent weapon to fight COVID-19. This drug is manufactured by using API, however, the Potency of this API material vary from batch to batch. To map this kind of requirement in SAP ERP, SAP calls it as Material Quantity Calculation.

Read More

What are the advantages of PCD Pharma Company?

Article | February 17, 2020

PCD Pharma stands for propaganda distribution. A PCD company gives brand name and support to its franchises. They also provide distribution rights and monopoly rights within a particular region. If a person wants to establish their business, it is a must for them to know the pros and cons of the business to make a sound decision. Needless to mention that PCD company has a lot to contribute in the medical filed. Worldwide in a medical field, A PCD Pharma Company is playing an essential and crucial role in the rapid growth. The pharma industry is progressing t a fast pace. The company uses the latest technologies for each brand which ensures the safety of products and accepts the responsibility of human health & life by providing better outcomes. To have a drug license number and company registration, the cost to establish the company is quite cost-effective that is15000-20000rs. So this gives people a brilliant opportunity to have their unit without digging a big hole in their bank balance. Indian produces exquisite quality products, which make pharma companies a considerable success.

Read More

Spotlight

iMEDGlobal Corporation

iMEDGlobal, an FMD K&L company, is an innovation-driven company providing platforms, services, and solutions to global life sciences clients to address critical business and scientific needs. Our platforms, services, and solutions include Pharmacovigilance, Regulatory Affairs, and Clinical Research. Led by a strong management team with decades of experience and thought leadership with leading pharmaceutical, biotech, medical devices, cosmetic and technology enterprises, iMEDGlobal is designed to deliver high-quality cost-effective solutions and services for our clients in the Americas, Europe, Asia and Australia. iMEDGlobal is a preferred partner to many top global life sciences companies who have placed their trust in our management team, infrastructure and capabilities.

Events